PF-06873600

Item number	Size	Manual	SDS	Delivery time	Price
LKT-P200600.1	1 mg	-	-	3 - 8 business days*	222.00€
LKT-P200600.5	5 mg	-	-	3 - 8 business days*	649.00€
LKT-P200600.10	10 mg	-	-	3 - 8 business days*	1,222.00€
LKT-P200600.25	25 mg	-	-	3 - 8 business days*	2,521.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

PF-06873600 is a selective inhibitor of CDK2/4/6 in multiple in vivo tumor models. SMILES:... more

Close menu

Product information "PF-06873600"

PF-06873600 is a selective inhibitor of CDK2/4/6 in multiple in vivo tumor models. SMILES: CC1(CCCC1N2C3=NC(=NC=C3C=C(C2=O)C(F)F)NC4CCN(CC4)S(=O)(=O)C)O

Keywords:	PF06873600, Ebvaciclib, 6-(difluoromethyl)-8-[(1R,2R)-2-hydroxy-2-methylcyclopentyl]-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrido[2,3-d]pyrimidin-7-one
Supplier:	LKT Laboratories
Supplier-Nr:	P200600

Properties

Application:	CDK2/4/6 inhibitor
MW:	471.52 D
Formula:	C20H27F2N5O4S
Purity:	>98%

Database Information

CAS :	2185857-97-8\| Matching products
KEGG ID :	K02206 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +20°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

View product citations for antibody P200600 on CiteAb

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "PF-06873600"

Write a review